Trials / Completed
CompletedNCT03785834
The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The Investigators wish to study the value of dermatologic testing assessments in differentiating between cellulitis and pseudocellulitis in the inpatient setting. The Investigators propose that by utilizing cutaneous biopsies and tissue cultures in patients that have been admitted to inpatient internal medicine teams, the investigators may be able to improve multiple measures of hospital efficiency in patients presenting with cellulitis-like symptoms, by more accurately recognizing cellulitis from pseudocellulitis. The patient will undergo encrypted digital imaging for his or her condition. This image will then be sent to the study investigators, along with basic clinical information on the skin evaluation form. The study investigators will develop a differential diagnosis and then the patient will undergo a skin biopsy. The patient will then be randomized to one of two arms using a random number generator: A) Skin biopsies and tissue cultures recorded and published in patient's medical chart as they would be in a standard of care procedure B) Skin biopsies and tissue cultures consultation performed but not published in the patient's medical chart unless medically necessary. Information will be collected from medical records in IHIS. Patients will be contacted by phone 30 days after discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Punch Biopsy | The patient will undergo two 6 mm punch biopsies into the affected extremity at the most proximal portion of the redness. |
Timeline
- Start date
- 2018-05-25
- Primary completion
- 2024-06-01
- Completion
- 2024-12-31
- First posted
- 2018-12-24
- Last updated
- 2025-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03785834. Inclusion in this directory is not an endorsement.